Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$175M |
| 2 |
Amazon
AMZN
|
+$94.9M |
| 3 |
Evergy
EVRG
|
+$79.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$61.1M |
| 5 |
Microsoft
MSFT
|
+$56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$283M |
| 2 |
MON
Monsanto Co
MON
|
+$197M |
| 3 |
TSMC
TSM
|
+$82.8M |
| 4 |
CSRA
CSRA Inc.
CSRA
|
+$43.5M |
| 5 |
DST
DST Systems Inc.
DST
|
+$37.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.06% |
| 2 | Financials | 14.34% |
| 3 | Healthcare | 12.26% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAMI
2351
Acadian Asset Management
AAMI
$3.2B
| $2.17M | ﹤0.01% |
152,400
+20,900
| +16% | +$320K |
|
2352
FRP Holdings
FRPH
$432M
| $2.17M | ﹤0.01% |
66,906
+1,806
| +3% | +$52.9K |
|
2353
Alaunos Therapeutics
TCRT
$4.66M
| $2.16M | ﹤0.01% |
4,759
+331
| +7% | +$210K |
|
|
ANCX
2354
DELISTED
Access National Corp
ANCX
| $2.15M | ﹤0.01% |
75,120
+2,304
| +3% | +$66K |
|
2355
Forrester Research
FORR
$221M
| $2.14M | ﹤0.01% |
51,092
+1,548
| +3% | +$66.3K |
|
2356
Lifecore Biomedical
LFCR
$165M
| $2.14M | ﹤0.01% |
143,725
+22,475
| +19% | +$312K |
|
2357
V2X
VVX
$2.7B
| $2.14M | ﹤0.01% |
69,308
-16,529
| -19% | -$559K |
|
|
MRTX
2358
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.13M | ﹤0.01% |
43,257
+35,499
| +458% | +$1.34M |
|
2359
NRC Health Common Stock
NRC
$432M
| $2.12M | ﹤0.01% |
56,597
+13,146
| +30% | +$458K |
|
2360
Titan Machinery
TITN
$423M
| $2.12M | ﹤0.01% |
135,980
+47,377
| +53% | +$917K |
|
2361
Tandem Diabetes Care
TNDM
$1.38B
| $2.11M | ﹤0.01% |
+95,686
| New | +$1.18M |
|
|
UPL
2362
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $2.1M | ﹤0.01% |
908,476
+32,221
| +4% | +$78.4K |
|
|
PSDO
2363
DELISTED
Presidio, Inc. Common Stock
PSDO
| $2.1M | ﹤0.01% |
160,119
+11,024
| +7% | +$160K |
|
|
AGS
2364
DELISTED
PlayAGS
AGS
| $2.1M | ﹤0.01% |
77,435
+35,331
| +84% | +$824K |
|
2365
Cytokinetics
CYTK
$10.4B
| $2.09M | ﹤0.01% |
251,805
+25,813
| +11% | +$215K |
|
|
BSTC
2366
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $2.08M | ﹤0.01% |
46,426
+3,514
| +8% | +$151K |
|
|
AXAS
2367
DELISTED
Abraxas Petroleum Corp
AXAS
| $2.07M | ﹤0.01% |
35,852
+14,229
| +66% | +$771K |
|
2368
VSE Corp
VSEC
$5.81B
| $2.07M | ﹤0.01% |
43,311
+2,890
| +7% | +$145K |
|
|
KERX
2369
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $2.07M | ﹤0.01% |
549,724
+12,773
| +2% | +$62.2K |
|
2370
GrafTech
EAF
$195M
| $2.06M | ﹤0.01% |
+11,455
| New | +$2.09M |
|
2371
1-800-Flowers.com
FLWS
$269M
| $2.05M | ﹤0.01% |
163,290
+19,704
| +14% | +$249K |
|
|
KEYW
2372
DELISTED
The KEYW Holding Corporation
KEYW
| $2.05M | ﹤0.01% |
234,506
-5,107
| -2% | -$42.8K |
|
2373
Greenlight Captial
GLRE
$552M
| $2.05M | ﹤0.01% |
144,247
-819
| -0.6% | -$12.5K |
|
2374
Evolution Petroleum
EPM
$129M
| $2.02M | ﹤0.01% |
205,297
-25,880
| -11% | -$238K |
|
|
PLYA
2375
DELISTED
Playa Hotels & Resorts
PLYA
| $2.01M | ﹤0.01% |
186,076
+20,364
| +12% | +$217K |
|
Similar funds
Charles Schwab's Q2 2018 Portfolio in Review
As of Q2 2018, Charles Schwab held 3,239 positions worth $137B, up 6.7% from $129B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $4.16B of net new capital in Q2 2018, opening 167 new positions and adding to 2,358 existing holdings. Its largest new stake was Evergy: 1,477,509 shares worth $83M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was TSMC, an estimated $82.8M trimmed.
- Charles Schwab's largest Q2 2018 buy was Evergy: 1,477,509 shares worth $83M.
- Charles Schwab added most to AT&T in Q2 2018, an estimated $175M increase.
- Charles Schwab's biggest Q2 2018 reduction was TSMC, cutting an estimated $82.8M.
- Charles Schwab fully exited Time Warner Inc in Q2 2018, selling an estimated $283M.
- Charles Schwab's ten largest holdings make up 14% of its $137B portfolio in Q2 2018.
- Charles Schwab opened 167 new positions and closed 125 in Q2 2018.
- Charles Schwab's portfolio value rose 6.7% quarter-over-quarter to $137B.
Based on Charles Schwab's 13F filing for Q2 2018, filed 8 Aug 2018.